Enrolling by invitationNCT06885515

Telomeres Length in Israeli Fibrotic ILD Patients

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Barzilai Medical Center
Principal Investigator
Ori Wand, Dr.
Barzilai University Medical Canter
Intervention
leukocyte telomere length (LTL) will be measured using the Telomere Restriction Fragment (TRF) Analysis method(diagnostic_test)
Enrollment
100 target
Eligibility
18 years · All sexes
Timeline
2026 – 2028

Study locations (2)

Collaborators

Tel Aviv Medical Center · Israel Society of Pulmonology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06885515 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis →

← Back to all trials